ENXTPA:RNO
ENXTPA:RNOAuto

Is Pressure On Renault Zoe Resale Values Reframing Renault’s EV Strategy Narrative (ENXTPA:RNO)?

In late 2025, data from the UK used-car market showed that popular secondhand electric vehicles lost significant value, with the Renault Zoe among the models experiencing some of the sharpest price declines as manufacturers cut prices on new EVs to meet regulatory sales targets. This rapid drop in used EV prices raises questions about residual values and consumer confidence in Renault’s electric line-up at a time when the group is investing heavily in its transition to battery-powered...
NYSE:PLD
NYSE:PLDIndustrial REITs

A Look At Prologis (PLD) Valuation After Analyst Upgrades And Mixed Earnings Expectations

Recent analyst upgrades for Prologis (PLD), including a move to Sector Outperform at Scotiabank, are arriving just as the company heads into an earnings report with mixed expectations. See our latest analysis for Prologis. At a share price of $133.21, Prologis has logged a 30 day share price return of 4.01% and a 90 day gain of 7.36%. The 1 year total shareholder return of 26.01% and 5 year total shareholder return of 51.39% point to momentum that has been building rather than fading. If...
TSX:BAM
TSX:BAMCapital Markets

Should Brookfield’s Asset‑Light Dividend Engine and US$100 Billion Dry Powder Reserve Shape TSX:BAM Investors’ Next Move?

In recent days, Brookfield Asset Management has attracted attention as a high‑quality dividend payer with an asset‑light model, reporting 11% revenue growth and 43% earnings growth over the last 12 months alongside more than US$100.00 billion of committed but un‑invested capital. This combination of income appeal, scalable fee potential, and a substantial pool of dry powder is sharpening investor focus on the company’s future fee‑earning capacity and capital deployment optionality. We’ll now...
CPSE:GUBRA
CPSE:GUBRALife Sciences

Gubra (CPSE:GUBRA) Is Down 7.9% After AMX0318 Milestone Deal With Amylyx - Has The Bull Case Changed?

Amylyx Pharmaceuticals recently selected AMX0318, a long-acting GLP-1 receptor antagonist discovered in collaboration with Gubra, as a development candidate for post-bariatric hypoglycemia and other rare diseases, triggering a US$4,000,000 milestone payment and positioning Gubra for more than US$50,000,000 in potential future milestones plus mid-single digit royalties. The move underlines how Gubra’s partnered peptide programs can translate preclinical research into tangible milestone income...
NasdaqGS:HALO
NasdaqGS:HALOBiotechs

Assessing Halozyme Therapeutics (HALO) Valuation After New ENHANZE Collaboration With Takeda

Takeda collaboration puts ENHANZE platform in focus Halozyme Therapeutics (HALO) has drawn fresh attention after a global collaboration and exclusive license agreement with Takeda, giving Takeda access to Halozyme’s ENHANZE drug delivery technology for vedolizumab in inflammatory bowel disease. See our latest analysis for Halozyme Therapeutics. While the Takeda agreement has put Halozyme back in the spotlight, the share price tells a mixed short term story. There has been a 1 day share price...
NYSE:DTE
NYSE:DTEIntegrated Utilities

A Look At DTE Energy (DTE) Valuation After EPS Guidance Reaffirmation And Major Data Center Agreement

DTE Energy (DTE) is back in focus after reaffirming its 2025 adjusted EPS guidance, outlining an early 2026 outlook, and securing a 1.4 GW data center agreement that has drawn fresh regulatory scrutiny. See our latest analysis for DTE Energy. The reaffirmed 2025 guidance, early 2026 outlook and the 1.4 GW data center agreement all arrive as DTE Energy’s share price sits at US$135.51. The 30 day share price return is 5.14% and the 1 year total shareholder return is 13.28%, suggesting momentum...
NYSE:ONTO
NYSE:ONTOSemiconductor

Is Analyst Optimism Around AI Packaging Quietly Reframing Onto Innovation’s (ONTO) Competitive Moat?

Onto Innovation’s leadership recently presented at the 28th Annual Needham Growth Conference in New York, outlining its semiconductor process control roadmap and positioning within advanced packaging and AI-related manufacturing trends. At the same time, the company has attracted growing institutional interest and options activity as analysts highlight its role in meeting tightening advanced packaging capacity needs. We’ll now examine how this strengthening analyst optimism around AI-driven...
TSE:9984
TSE:9984Wireless Telecom

SoftBank Group (TSE:9984) Valuation Check After Recent Share Price Weakness

Recent share performance snapshot SoftBank Group (TSE:9984) has drawn attention after a recent pullback, with the stock showing a 1% decline over the past day, a 4% slide over the past month, and a 30% drop over the past 3 months. See our latest analysis for SoftBank Group. Stepping back, the recent 3 month share price return of negative 30.35% sits against a year to date share price return of negative 13.11%. At the same time, the 1 year total shareholder return of 77.34% points to a very...
ASX:MND
ASX:MNDConstruction

Monadelphous Group (ASX:MND) Is Up 10.5% After New A$300m Rio Tinto Contract Win

Monadelphous Group has secured a five-year, A$300 million maintenance contract from Rio Tinto in the Pilbara, extending a relationship that spans more than three decades. This long-term award deepens Monadelphous’ role as a key maintenance partner to tier-one miners, reinforcing the visibility of work with blue-chip clients. We’ll now examine how this new A$300 million Rio Tinto maintenance contract influences Monadelphous’ investment narrative and revenue visibility. We've found 12 US...
NasdaqGM:XNCR
NasdaqGM:XNCRBiotechs

A Look At Xencor (XNCR) Valuation After New XmAb819 Renal Cancer Data And Pipeline Milestone Update

Xencor (XNCR) recently outlined 2026 priorities for its XmAb platform, highlighting early clinical data for renal cell carcinoma candidate XmAb819 and setting out timelines for multiple oncology and autoimmune milestones that could influence investor expectations. See our latest analysis for Xencor. Despite the fresh 2026 pipeline update, Xencor’s recent share price momentum has been weak, with a 30 day share price return of a 19.05% decline and a 1 year total shareholder return of a 33.52%...
NYSEAM:ROLR
NYSEAM:ROLRHospitality

Why High Roller Technologies (ROLR) Is Up 541.8% After Crypto.com U.S. Prediction Markets Deal Announcement

In mid-January 2026, High Roller Technologies, Inc. announced a binding Letter of Intent with Crypto.com | Derivatives North America to power a regulated, event-based prediction markets product in the United States, alongside multiple non-binding marketing LOIs with social-first sports media platforms to support its planned launch. A distinctive aspect of this move is High Roller’s effort to pair regulated prediction-market infrastructure with billion-scale social media reach from partners...
NasdaqGS:WDFC
NasdaqGS:WDFCHousehold Products

WD-40 (WDFC) Valuation Check After Flat Quarter Timing Issues And Higher Capital Returns

WD-40 (WDFC) is back in focus after its latest quarter showed flat sales and lower GAAP profit, tied mainly to timing issues with Asia Pacific distributors rather than a pullback in underlying demand. See our latest analysis for WD-40. That backdrop helps explain recent trading, with the share price at US$204.99 after a 7 day share price return of 7.89% and a 90 day share price return of 5.40%. At the same time, the 1 year total shareholder return is 9.92% lower and the 3 year total...
NasdaqGM:HRMY
NasdaqGM:HRMYPharmaceuticals

Can Harmony Biosciences (HRMY) Turn WAKIX Ambitions and CNS Pipeline Into a Durable Growth Engine?

Harmony Biosciences Holdings recently presented at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, where CEO Jeffrey M. Dayno outlined the company’s latest business and pipeline updates. The company underscored its expectation that WAKIX could achieve more than US$1.00 billion in 2026 revenue while advancing next-generation pitolisant formulations and additional CNS programs to extend the franchise and diversify growth. We’ll now examine how Harmony’s blockbuster WAKIX...
ASX:SS1
ASX:SS1Metals and Mining

Assessing Sun Silver’s Valuation After New Maverick Springs Assay Results

Sun Silver (ASX:SS1) is back on investors’ radar after new assay results from its Maverick Springs silver gold project in Nevada highlighted thick mineralised intercepts that align with previously outlined resource grades. See our latest analysis for Sun Silver. The recent Maverick Springs assay update has arrived alongside strong short term share price momentum, with a 7 day share price return of 15.0% and a 30 day share price return of 34.0%. The 1 year total shareholder return of 181.9%...
SGX:C09
SGX:C09Real Estate

Does Newport Launch And First Sponsor Losses Change The Bull Case For City Developments (SGX:C09)?

City Developments Ltd recently held a preview opening for Newport Residences, a 246-unit freehold project on Anson Road, ahead of sales bookings set for 31 January and a results update planned for late February. At the same time, the group flagged profit guidance issues at associated company First Sponsor Group, where foreign exchange movements and property valuation pressures contributed to net losses, highlighting how linked investments can influence sentiment toward CDL’s broader...
NYSE:LXP
NYSE:LXPIndustrial REITs

LXP Industrial Trust (LXP) Valuation Check After New Credit Facility And Term Loan Refinancing

LXP Industrial Trust (LXP) has overhauled its debt profile by closing a new US$600 million senior unsecured revolving credit facility and refinancing a US$250 million unsecured term loan with longer maturities and lower stated borrowing costs. See our latest analysis for LXP Industrial Trust. The financing update comes after a period of steady share price momentum, with LXP Industrial Trust’s 90 day share price return of 8.30% and year to date share price return of 3.43%, while the 1 year...
NYSE:CTRI
NYSE:CTRIConstruction

Assessing Centuri Holdings (CTRI) Valuation After Recent Share Price Momentum

Why Centuri Holdings Is On Investors’ Radar Centuri Holdings (CTRI) has drawn fresh attention after recent trading, with the stock showing positive moves over the past week, month and past 3 months, prompting investors to reassess its utility infrastructure-focused story. See our latest analysis for Centuri Holdings. At a share price of $27.80, Centuri’s recent 4.2% 1 day share price return and 10.6% 30 day share price return contribute to a 90 day move of 38.2%, while the 1 year total...
NYSE:BAH
NYSE:BAHProfessional Services

A Look At Booz Allen Hamilton (BAH) Valuation After New Andreessen Horowitz Government Tech Partnership

Why the new a16z partnership matters for Booz Allen Hamilton Holding (BAH) Booz Allen Hamilton Holding (BAH) just became Andreessen Horowitz’s first Technology Acceleration Partner for Governments, tying its federal mission work directly to a16z portfolio companies focused on AI, cybersecurity, autonomy, and electronic warfare. For you as an investor, this collaboration connects Booz Allen’s government reach and technical know how with growth stage startups that are working on tools for...
NYSE:CON
NYSE:CONHealthcare

Is Concentra (CON) Using Inflation-Linked Pricing to Quietly Redefine Its Occupational Health Profit Engine?

On 14 January 2026, Concentra Group Holdings Parent, Inc. presented at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, outlining its business performance and financial framework to investors. The company underscored its role as a leading U.S. occupational health provider, treating roughly one in four workplace injuries across more than 1,000 locations while relying on non‑GAAP metrics such as Adjusted EBITDA and ROIC to assess performance and capital allocation. Next,...
TSX:PEY
TSX:PEYOil and Gas

Peyto (TSX:PEY) Affirms Dividend and Refinances Debt Is Its Capital Structure Strategy Evolving?

Peyto Exploration & Development Corp. has confirmed that its monthly dividend for January 2026 of CA$0.11 per common share will be paid on February 13, 2026, to shareholders of record as of January 31, 2026, and recently issued CA$100,000,000 in 5.03% senior secured notes maturing in 2033 to refinance maturing debt. This combination of a reaffirmed monthly dividend and disciplined balance sheet management through like-for-like debt refinancing underpins investors’ focus on Peyto’s income...
NYSE:HE
NYSE:HEElectric Utilities

A Look At Hawaiian Electric Industries (HE) Valuation As Wildfire Settlements And New Legislation Reset Risk Profile

Hawaiian Electric Industries (HE) is back in focus after reaching preliminary agreements to settle eight shareholder lawsuits tied to wildfire risk disclosures, funded by US$100 million in insurance proceeds and accompanied by new Hawaii wildfire legislation. See our latest analysis for Hawaiian Electric Industries. The wildfire settlement progress and new Hawaii legislation arrive after a sharp rebound in sentiment, with a 20.72% 1 month share price return and a 58.10% 1 year total...
NYSE:AMH
NYSE:AMHResidential REITs

A Look At American Homes 4 Rent (AMH) Valuation After Recent Wave Of Analyst Downgrades

Why analyst downgrades have put American Homes 4 Rent in focus Several major Wall Street firms recently lowered their views on American Homes 4 Rent (AMH). This has pushed the stock higher on many investors’ watchlists and raised fresh questions about the REIT’s current pricing. See our latest analysis for American Homes 4 Rent. At a share price of $32.36, American Homes 4 Rent has seen short term momentum pick up, with a 1-day share price return of 2.02% and a 7-day share price return of...
SGX:EB5
SGX:EB5Food

A Look At First Resources (SGX:EB5) Valuation After Palm Oil Weakness Profit Taking And Earnings Ahead

What triggered the latest move in First Resources? First Resources (SGX:EB5) opened pre market at S$1.99 on 17 Jan 2026, about 6.1% lower, as palm oil benchmarks softened and traders took profit after strong 2025 gains. The pullback also comes as investors position ahead of the 27 Feb 2026 earnings release and track crude palm oil prices, Indonesian export rules, and potential changes to biodiesel blending mandates. See our latest analysis for First Resources. While the latest pullback has...
NYSE:WMS
NYSE:WMSBuilding

A Look At Advanced Drainage Systems (WMS) Valuation After Recent Share Price Momentum

Recent performance snapshot Advanced Drainage Systems (WMS) has drawn fresh attention after a period of steady share moves, with the stock recently closing at $159.30 and posting positive returns over the past month and past 3 months. See our latest analysis for Advanced Drainage Systems. Beyond the recent share price move, Advanced Drainage Systems has built a clear upswing, with a 10.1% 30 day share price return alongside a 27.6% 1 year total shareholder return. This suggests momentum has...